Related Experiment Video
Updated: Aug 8, 2025
08:05
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
14.3K
COVID-19 and Cavitary Lesion in Lung
Avinash Vangara1, Tara Hendrickson Rahmlow1, Dedeepya Gullapalli1
1Internal Medicine Residency Program, Appalachian Regional Healthcare, Harlan, USA.
Cureus
|February 27, 2023
Summary
This case study emphasizes that bacterial coinfections, like MRSA, are critical in COVID-19 patients with lung lesions. Early identification and treatment of secondary infections are vital for patient recovery.
Area of Science:
- Infectious Diseases
- Pulmonology
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, presents with diverse clinical manifestations, from asymptomatic to critical illness.
- Viral respiratory infections, including COVID-19, increase susceptibility to secondary bacterial infections.
- Bacterial coinfections and superinfections significantly contributed to mortality during the COVID-19 pandemic.
Observation:
- A 76-year-old male with COVID-19 presented with shortness of breath and cavitary lung lesions.
- Bronchoalveolar lavage cultures identified methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium gordonae.
- The patient developed a pulmonary embolism after anticoagulation was stopped due to hemoptysis.
Findings:
- Bacterial coinfection, specifically MRSA and M. gordonae, was identified in a COVID-19 patient with cavitary lung lesions.
- The case illustrates the complexity of managing secondary bacterial infections alongside COVID-19.
- Complications such as pulmonary embolism can arise, necessitating careful treatment adjustments.
Implications:
- Highlights the importance of suspecting bacterial coinfection in COVID-19 patients presenting with cavitary lung lesions.
- Underscores the need for judicious antimicrobial stewardship in managing coinfections.
- Emphasizes the necessity of close patient monitoring for complete recovery from COVID-19 and associated complications.
Related Concept Videos
01:28Pulmonary Tuberculosis V
223
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
223
01:13Pleura of the Lungs
2.6K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
2.6K
01:20COPD: Pathogenesis and Clinical Features
406
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
406
01:17Other Pulmonary Disorders
885
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
885
01:31Pulmonary Tuberculosis III
402
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
402
01:27Pneumothorax-II
243
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
243